Complete Filing Data
Sana Biotechnology, Inc. reported Stockholders Equity of $160.88 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Sana Biotechnology, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$244.2M | -$266.8M | -$283.3M | -$269.5M | -$355.9M | -$285.3M | -$130.8M |
| Research And Development Expense | $132.0M | $215.7M | $261.8M | $285.9M | $248.6M | $132.9M | $99.6M |
| Other Nonoperating Income Expense | $2.3M | -$4.5M | -$52.0K | -$674.0K | $305.0K | $97.0K | -$29.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $14.0K | $74.0K | $4.3M | -$3.0M | -$1.4M | $4.0K | $26.0K |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $14.0K | $74.0K | $4.3M | -$3.0M | -$1.4M | ||
| Operating Income Loss | -$250.3M | -$272.7M | -$293.1M | -$272.6M | -$356.9M | -$286.1M | -$141.2M |
| Interest Income Expense Nonoperating Net | $3.8M | $10.5M | $9.9M | $3.8M | $676.0K | $747.0K | $2.9M |
| General And Administrative Expense | $44.3M | $64.0M | $73.3M | $71.6M | $50.4M | $28.3M | $21.8M |
| Comprehensive Income Net Of Tax | -$244.2M | -$266.7M | -$279.0M | -$272.4M | -$357.3M | -$285.3M | -$130.8M |
| Research And Development Related Success Payments And Contingent Consideration | $29.4M | -$8.9M | -$49.0M | -$84.9M | $57.9M | $124.9M | $19.8M |
| Operating Expenses | $250.3M | $272.7M | $293.1M | $272.6M | $356.9M | $286.1M | $141.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$42.2M | -$93.8M | -$49.4M | -$59.9M | -$50.3M | -$107.5M | $984.0K | -$114.0M | -$82.1M | -$85.1M | -$72.5M | -$31.4M | -$83.3M | $18.7M | -$180.6M | -$51.5M | -$87.8M | -$32.9M |
| Research And Development Expense | $30.1M | $29.8M | $37.2M | $53.2M | $60.9M | $56.4M | $65.6M | $73.0M | $67.2M | $76.7M | $72.5M | $72.7M | $53.2M | $45.0M | $41.9M | $40.1M | $30.0M | $27.3M |
| Other Nonoperating Income Expense | $360.0K | $598.0K | $249.0K | -$742.0K | -$4.1M | $215.0K | $303.0K | -$84.0K | -$47.0K | -$106.0K | -$198.0K | -$102.0K | $10.0K | $1.0K | $13.0K | $44.0K | $19.0K | $5.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $21.0K | $0.00 | -$14.0K | $73.0K | -$4.0K | $45.0K | $663.0K | $1.3M | $2.2M | -$67.0K | -$1.2M | -$3.8M | -$95.0K | -$43.0K | $26.0K | $32.0K | $7.0K | -$10.0K |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $21.0K | -$14.0K | $73.0K | -$4.0K | $45.0K | $663.0K | $1.3M | $2.2M | -$67.0K | -$1.2M | -$3.8M | -$95.0K | -$43.0K | $26.0K | $32.0K | $7.0K | -$10.0K | |
| Operating Income Loss | -$43.5M | -$95.0M | -$50.6M | -$61.8M | -$49.4M | -$110.7M | -$2.2M | -$116.3M | -$84.1M | -$86.2M | -$72.9M | -$31.7M | -$83.4M | $18.6M | -$180.8M | -$51.6M | -$87.9M | -$33.3M |
| Interest Income Expense Nonoperating Net | $1.0M | $577.0K | $992.0K | $2.6M | $3.2M | $3.0M | $2.9M | $2.4M | $2.0M | $1.2M | $637.0K | $339.0K | $158.0K | $130.0K | $121.0K | $148.0K | $79.0K | $395.0K |
| General And Administrative Expense | $10.3M | $10.3M | $11.5M | $14.1M | $16.4M | $16.3M | $19.2M | $16.6M | $16.8M | $15.5M | $18.3M | $14.4M | $13.4M | $12.5M | $11.8M | $7.1M | $6.0M | $6.0M |
| Comprehensive Income Net Of Tax | -$42.1M | -$93.8M | -$49.4M | -$59.9M | -$50.3M | -$107.4M | $1.6M | -$112.7M | -$79.9M | -$85.2M | -$73.6M | -$35.3M | -$83.4M | $18.6M | -$180.6M | -$51.4M | -$87.8M | -$32.9M |
| Research And Development Related Success Payments And Contingent Consideration | $3.1M | $10.3M | $2.0M | -$5.5M | -$27.9M | $38.0M | -$82.6M | $26.7M | $120.0K | -$6.1M | -$17.9M | -$55.4M | $16.8M | -$76.0M | $127.1M | $4.5M | $51.9M | |
| Operating Expenses | $43.5M | $95.0M | $50.6M | $61.8M | $49.4M | $110.7M | $2.2M | $116.3M | $84.1M | $86.2M | $72.9M | $31.7M | $83.4M | $180.8M | $51.6M | $33.3M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $160.9M | $250.5M | $287.5M | $499.3M | $728.5M | -$421.2M | -$142.5M | -$13.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $76.1M | $131.4M | $137.3M | $187.3M | $261.8M | $126.9M | $81.8M | $31.4M |
| Change In Fair Value Of Success Payment Liabilities | $14.7M | -$8.2M | -$8.2M | -$81.5M | $26.0M | $72.1M | $1.9M | |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $14.8M | -$638.0K | -$40.8M | -$3.4M | $31.8M | $52.8M | $17.9M | |
| Operating Lease Right Of Use Asset Amortization Expense | $9.2M | $9.7M | $13.3M | $12.1M | $6.8M | $4.3M | $2.1M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$55.3M | -$6.0M | -$49.9M | -$74.6M | $134.9M | $45.1M | $50.4M | |
| Cash And Cash Equivalents At Carrying Value | $71.9M | $127.6M | $133.5M | $176.8M | $253.0M | $124.8M | ||
| Success Payment Liabilities Noncurrent | $19.2M | $4.6M | $12.8M | $21.0M | $97.5M | $76.5M | ||
| Retained Earnings Accumulated Deficit | -$1.85B | -$1.60B | -$1.34B | -$1.05B | -$785.4M | -$429.4M | ||
| Property Plant And Equipment Net | $26.9M | $77.3M | $70.7M | $66.9M | $65.5M | $46.8M | ||
| Prepaid Expense And Other Assets Current | $6.1M | $4.5M | $4.5M | $14.4M | $7.1M | $6.2M | ||
| Other Assets Noncurrent | $3.2M | $5.1M | $6.4M | $4.6M | $5.0M | $190.0K | ||
| Operating Lease Right Of Use Asset | $38.3M | $58.0M | $74.9M | $92.5M | $96.3M | $63.2M | ||
| Operating Lease Liability Noncurrent | $63.9M | $81.7M | $90.9M | $95.9M | $101.8M | $68.2M | ||
| Operating Lease Liability Current | $14.9M | $12.5M | $13.2M | $12.4M | $9.2M | $3.7M | ||
| Marketable Securities Current | $66.5M | $24.9M | $71.7M | $247.2M | $298.0M | $253.5M | ||
| Liabilities Current | $78.7M | $45.4M | $64.5M | $111.5M | $99.2M | $31.5M | ||
| Liabilities And Stockholders Equity | $416.9M | $501.0M | $565.3M | $822.7M | $1.13B | $730.3M | ||
| Liabilities | $256.0M | $250.5M | $277.8M | $323.4M | $400.9M | $298.6M | ||
| Intangible Assets Net Excluding Goodwill | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | ||
| Goodwill | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | ||
| Employee Related Liabilities Current | $13.2M | $14.4M | $23.7M | $26.4M | $21.1M | $16.0M | ||
| Common Stock Value | $27.0K | $22.0K | $20.0K | $19.0K | $18.0K | $2.0K | ||
| Business Combination Contingent Consideration Liability Noncurrent | $83.5M | $109.0M | $109.6M | $95.0M | $102.4M | $121.9M | ||
| Assets Current | $148.7M | $160.8M | $213.5M | $444.4M | $558.1M | $384.5M | ||
| Assets | $416.9M | $501.0M | $565.3M | $822.7M | $1.13B | $730.3M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $28.0K | $14.0K | -$60.0K | -$4.3M | -$1.4M | $30.0K | ||
| Accrued Liabilities And Other Liabilities | $8.7M | $13.2M | $23.5M | $14.5M | $10.3M | $9.5M | ||
| Accounts Payable Current | $1.7M | $5.2M | $4.1M | $2.9M | $2.2M | $2.3M | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $0.00 | $9.0M | $21.1M | $40.0M | $26.5M | $48.9M | |
| Restricted Cash Current | $4.2M | $3.8M | $3.8M | $6.1M | ||||
| Restricted Cash Noncurrent | $4.4M | $8.8M | $2.1M | |||||
| Marketable Securities Noncurrent | $10.1M | $195.9M | $33.7M | |||||
| Cash Received For Tenant Improvement Allowances | $891.0K | $7.5M | $12.5M | $2.0M | $5.4M | |||
| Other Liabilities Noncurrent | $10.6M | $9.9M | $540.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $195.3M | $122.6M | $209.1M | $292.5M | $339.6M | $375.1M | $365.9M | $355.0M | $428.3M | $566.0M | $639.5M | $701.7M | $830.1M | $905.9M | $882.0M | -$311.2M | -$260.9M | -$174.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $107.6M | $75.5M | $100.3M | $130.8M | $138.8M | $180.9M | $172.3M | $184.3M | $171.0M | $173.9M | $205.2M | $197.3M | $442.5M | $677.3M | $752.8M | $151.4M | $457.2M | $91.4M |
| Change In Fair Value Of Success Payment Liabilities | $93.0K | $32.6M | -$5.3M | -$54.9M | $115.7M | $552.0K | ||||||||||||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $1.9M | $5.4M | $5.5M | -$528.0K | $11.4M | $362.0K | ||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $2.2M | $3.3M | $3.4M | $2.6M | $1.4M | $784.0K | ||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$31.1M | $43.5M | -$16.3M | -$64.5M | $625.9M | $9.6M | ||||||||||||
| Cash And Cash Equivalents At Carrying Value | $103.4M | $71.3M | $96.1M | $127.0M | $135.0M | $177.1M | $168.4M | $173.8M | $160.5M | $163.3M | $194.7M | $188.5M | $433.7M | $675.1M | $750.7M | |||
| Success Payment Liabilities Noncurrent | $13.7M | $8.6M | $4.6M | $15.1M | $20.8M | $45.4M | $12.4M | $36.5M | $15.7M | $35.7M | $33.5M | $47.6M | $129.2M | $104.0M | $187.2M | |||
| Retained Earnings Accumulated Deficit | -$1.79B | -$1.75B | -$1.65B | -$1.56B | -$1.50B | -$1.45B | -$1.25B | -$1.25B | -$1.14B | -$974.4M | -$889.3M | -$816.8M | -$674.6M | -$591.4M | -$610.0M | |||
| Property Plant And Equipment Net | $29.9M | $33.1M | $73.7M | $82.8M | $85.9M | $81.6M | $68.4M | $62.7M | $64.3M | $67.3M | $67.8M | $68.7M | $63.4M | $58.7M | $51.0M | |||
| Prepaid Expense And Other Assets Current | $4.5M | $5.6M | $3.8M | $7.3M | $8.0M | $6.3M | $7.1M | $6.6M | $14.5M | $8.4M | $9.6M | $10.8M | $9.1M | $7.5M | $7.2M | |||
| Other Assets Noncurrent | $3.2M | $3.2M | $4.4M | $5.6M | $6.3M | $7.1M | $6.5M | $6.9M | $4.6M | $4.7M | $4.8M | $4.9M | $591.0K | $598.0K | $644.0K | |||
| Operating Lease Right Of Use Asset | $40.7M | $43.0M | $54.8M | $61.0M | $63.2M | $71.6M | $77.2M | $94.7M | $98.1M | $95.7M | $98.9M | $97.1M | $84.8M | $60.3M | $61.8M | |||
| Operating Lease Liability Noncurrent | $67.9M | $71.7M | $78.3M | $85.5M | $88.6M | $92.9M | $83.4M | $100.2M | $101.6M | $99.9M | $103.0M | $102.5M | $92.4M | $66.1M | $66.3M | |||
| Operating Lease Liability Current | $14.4M | $13.8M | $13.0M | $10.6M | $10.0M | $13.2M | $13.5M | $12.9M | $12.9M | $11.9M | $10.7M | $9.6M | $6.5M | $6.0M | $3.9M | |||
| Marketable Securities Current | $49.7M | $1.4M | $8.6M | $72.0M | $116.7M | $134.0M | $100.1M | $152.1M | $188.9M | $322.4M | $290.1M | $323.9M | $170.0M | $177.7M | $209.6M | |||
| Liabilities Current | $35.5M | $33.4M | $33.2M | $47.0M | $50.7M | $52.9M | $66.6M | $112.1M | $102.8M | $114.8M | $97.1M | $93.5M | $92.0M | $42.8M | $35.2M | |||
| Liabilities And Stockholders Equity | $435.4M | $361.6M | $445.5M | $559.4M | $618.7M | $681.4M | $631.4M | $707.1M | $746.9M | $898.1M | $971.1M | $1.05B | $1.23B | $1.26B | $1.30B | |||
| Liabilities | $240.1M | $239.1M | $236.4M | $266.9M | $279.0M | $306.2M | $265.6M | $352.1M | $318.7M | $332.1M | $331.6M | $346.0M | $402.7M | $353.9M | $422.5M | |||
| Intangible Assets Net Excluding Goodwill | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | |||
| Goodwill | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | |||
| Employee Related Liabilities Current | $11.3M | $9.4M | $9.4M | $18.1M | $15.6M | $14.0M | $24.3M | $19.7M | $17.0M | $24.5M | $18.0M | $16.9M | $20.2M | $15.3M | $10.8M | |||
| Common Stock Value | $26.0K | $23.0K | $23.0K | $22.0K | $22.0K | $22.0K | $20.0K | $20.0K | $19.0K | $19.0K | $19.0K | $19.0K | $18.0K | $18.0K | $18.0K | |||
| Business Combination Contingent Consideration Liability Noncurrent | $115.1M | $117.1M | $110.8M | $111.9M | $111.6M | $115.0M | $103.2M | $103.3M | $98.6M | $81.7M | $98.0M | $102.3M | $88.5M | $140.5M | $133.3M | |||
| Assets Current | $161.8M | $82.5M | $112.7M | $210.1M | $263.5M | $321.3M | $279.5M | $338.6M | $369.9M | $500.3M | $494.4M | $523.2M | $612.8M | $860.3M | $967.5M | |||
| Assets | $435.4M | $361.6M | $445.5M | $559.4M | $618.7M | $681.4M | $631.4M | $707.1M | $746.9M | $898.1M | $971.1M | $1.05B | $1.23B | $1.26B | $1.30B | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $21.0K | $0.00 | $0.00 | $54.0K | -$19.0K | -$15.0K | -$202.0K | -$865.0K | -$2.1M | -$6.4M | -$6.3M | -$5.2M | -$82.0K | $13.0K | $56.0K | |||
| Accrued Liabilities And Other Liabilities | $8.0M | $7.9M | $9.8M | $15.4M | $21.3M | $19.7M | $18.9M | $18.0M | $13.3M | $15.0M | $14.0M | $11.3M | $12.9M | $12.8M | $11.2M | |||
| Accounts Payable Current | $1.9M | $2.3M | $989.0K | $3.0M | $3.8M | $6.1M | $9.9M | $3.1M | $2.3M | $4.0M | $3.1M | $4.8M | $3.9M | $3.7M | $4.3M | |||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $9.0M | $3.4M | $14.3M | |||||||||||||||
| Restricted Cash Current | $4.2M | $4.2M | $4.2M | $3.8M | $3.8M | $3.8M | $3.8M | $6.7M | $6.1M | $6.1M | ||||||||
| Restricted Cash Noncurrent | $4.4M | $4.4M | $4.4M | $10.5M | $8.8M | $8.8M | $2.1M | $2.1M | ||||||||||
| Marketable Securities Noncurrent | $5.8M | $25.8M | $94.8M | $145.0M | $262.4M | $77.9M | $21.6M | |||||||||||
| Cash Received For Tenant Improvement Allowances | $891.0K | $6.1M | ||||||||||||||||
| Other Liabilities Noncurrent | $7.9M | $8.2M | $9.4M | $7.5M | $7.3M | $539.0K | $539.0K | $539.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $25.5M | $37.7M | $35.5M | $38.3M | $22.4M | $5.8M | $1.5M |
| Proceeds From Sale And Maturity Of Marketable Securities | $46.6M | $276.9M | $349.8M | $310.1M | $280.0M | $158.7M | $83.0M |
| Payments To Acquire Property Plant And Equipment | $938.0K | $33.4M | $20.0M | $20.9M | $29.9M | $23.9M | $26.1M |
| Net Cash Provided By Used In Operating Activities | -$143.8M | -$223.2M | -$253.6M | -$290.1M | -$251.1M | -$138.0M | -$85.5M |
| Net Cash Provided By Used In Investing Activities | -$40.2M | $17.5M | $172.0M | $210.6M | -$245.8M | -$252.6M | -$87.9M |
| Net Cash Provided By Used In Financing Activities | $128.7M | $199.7M | $31.6M | $4.9M | $631.8M | $435.7M | $223.7M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.2M | $3.5M | -$8.1M | $6.0M | $861.0K | $1.4M | $4.3M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$4.7M | -$8.4M | -$1.5M | $10.9M | $5.8M | $5.5M | $9.5M |
| Increase Decrease In Accounts Payable | -$3.5M | $1.4M | $1.0M | $1.1M | -$266.0K | $2.0M | -$421.0K |
| Payments To Acquire Marketable Securities | $87.3M | $226.1M | $157.7M | $78.7M | $491.4M | $387.4M | $141.5M |
| Increase Decrease In Operating Lease Right Of Use Assets And Liabilities | $3.0M | -$9.3M | -$11.0M | -$1.6M | -$5.1M | -$91.0K | -$5.7M |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 2.7M | 11.0M | 4.6M | 4.3M | |||
| Proceeds From Issuance Of Common Stock | $126.4M | $181.0M | $27.0M | $4.3M | $5.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $7.0M | $9.1M | $8.8M | $7.8M | $4.2M | $755.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $18.2M | $53.0M | $85.3M | $45.8M | $100.3M | $44.8M |
| Payments To Acquire Property Plant And Equipment | $136.0K | $15.8M | $2.2M | $7.5M | $6.4M | $5.6M |
| Net Cash Provided By Used In Operating Activities | -$48.7M | -$65.6M | -$79.3M | -$77.7M | -$49.9M | -$29.5M |
| Net Cash Provided By Used In Investing Activities | $16.6M | -$77.2M | $62.7M | $12.5M | $49.1M | $39.2M |
| Net Cash Provided By Used In Financing Activities | $982.0K | $186.4M | $236.0K | $652.0K | $626.7M | $2.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.4M | $2.4M | $106.0K | $3.2M | $1.6M | $501.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$8.9M | -$9.8M | -$10.3M | -$2.5M | -$3.1M | -$3.0M |
| Increase Decrease In Accounts Payable | -$4.2M | -$1.1M | -$354.0K | $1.9M | $1.6M | $2.4M |
| Payments To Acquire Marketable Securities | $1.7M | $114.4M | $20.4M | $25.7M | $44.8M | |
| Increase Decrease In Operating Lease Right Of Use Assets And Liabilities | -$891.0K | -$5.8M | $8.0K | -$372.0K | ||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 1.1M | 4.9M | 236.0K | 652.0K | 298.0K | |
| Proceeds From Issuance Of Common Stock | $236.0K | $652.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.96 | -$1.16 | -$1.46 | -$1.43 | -$2.14 | -$21.92 | -$26.68 |
| Weighted Average Number Of Shares Outstanding Basic | 253.2M | 230.9M | 194.5M | 188.3M | 166.4M | 13.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 253.2M | 230.9M | 194.5M | 188.3M | 166.4M | 13.0M | |
| Earnings Per Share Basic | $-0.96 | $-1.16 | $-1.46 | $-1.43 | $-2.14 | $-21.92 | |
| Preferred Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 0.00 | |
| Common Stock Shares Authorized | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 707.0M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 266.7M | 223.9M | 197.9M | 191.0M | 184.9M | 16.2M | |
| Common Stock Shares Issued | 266.7M | 223.9M | 197.9M | 191.0M | 184.9M | 16.2M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.16 | -$0.39 | -$0.21 | -$0.25 | -$0.21 | -$0.49 | $0.00 | -$0.59 | -$0.43 | -$0.45 | -$0.39 | -$0.17 | -$0.46 | $0.09 | -$1.52 | -$3.76 | -$7.18 | -$3.04 |
| Weighted Average Number Of Shares Outstanding Basic | 260.5M | 238.4M | 237.6M | 235.4M | 234.4M | 217.3M | 197.0M | 192.5M | 191.2M | 189.3M | 187.6M | 186.0M | 181.8M | 179.9M | 12.2M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 260.5M | 238.4M | 237.6M | 235.4M | 234.4M | 217.3M | 200.5M | 192.5M | 191.2M | 189.3M | 187.6M | 186.0M | 181.8M | 190.5M | 12.2M | |||
| Earnings Per Share Basic | $-0.16 | $-0.39 | $-0.21 | $-0.25 | $-0.21 | $-0.49 | $0.00 | $-0.59 | $-0.43 | $-0.45 | $-0.39 | $-0.17 | $-0.46 | $0.10 | $-7.18 | |||
| Preferred Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | |||
| Common Stock Shares Authorized | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 262.3M | 230.5M | 225.5M | 223.1M | 222.2M | 221.3M | 197.1M | 196.9M | 191.4M | 189.9M | 188.4M | 186.6M | 182.9M | 180.6M | 178.9M | |||
| Common Stock Shares Issued | 262.3M | 230.5M | 225.5M | 223.1M | 222.2M | 221.3M | 197.1M | 196.9M | 191.4M | 189.9M | 188.4M | 186.6M | 182.9M | 180.6M | 178.9M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $2.3M | $9.5M | $2.0M | $2.3M | $3.2M | $149.0K | $1.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $25.5M | $37.7M | $35.5M | $38.3M | $22.4M | $5.8M | $1.5M |
| Depreciation | $15.6M | $11.1M | $5.9M | $1.8M | |||
| Other Noncash Income Expense | $11.0M | $11.1M | $13.3M | $9.3M | $3.1M | -$233.0K | $592.0K |
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $0.00 | $9.5M | $1.2M | $3.0M | $3.1M | $2.5M |
| Additional Paid In Capital | $2.01B | $1.86B | $1.63B | $1.56B | $1.52B | $8.2M | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $350.0K | $1.5M | $2.6M | $2.1M | $2.2M | ||
| Stock Issued During Period Shares Stock Options Exercised | 978.0K | 2.6M | 1.1M | 1.1M | 1.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $158.0K | $148.0K | $1.1M | $1.9M | $2.4M | $4.9M | $192.0K | $691.0K | $331.0K | $897.0K | $571.0K | $652.0K | $1.6M | $333.0K | $298.0K | $9.0K | $35.0K | $2.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.5M | $6.6M | $7.0M | $10.8M | $11.4M | $9.1M | $9.0M | $9.8M | $8.8M | $10.1M | $9.9M | $7.8M | $6.0M | $4.9M | $4.2M | $1.2M | $1.1M | $755.0K |
| Depreciation | $3.2M | $2.9M | $3.6M | $4.1M | $3.9M | $3.7M | $4.5M | $4.5M | $4.3M | $4.0M | $3.8M | $3.6M | $2.8M | $2.6M | $2.2M | $1.6M | $1.4M | $1.3M |
| Other Noncash Income Expense | $3.3M | $4.9M | $2.9M | $1.4M | $1.0M | -$350.0K | ||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $8.4M | $968.0K | $3.4M | $3.2M | $644.0K | ||||||||||||
| Additional Paid In Capital | $1.99B | $1.87B | $1.86B | $1.85B | $1.84B | $1.82B | $1.62B | $1.61B | $1.57B | $1.55B | $1.54B | $1.52B | $1.50B | $1.50B | $1.49B | |||
| Stock Issued During Period Value Employee Stock Purchase Plan | $185.0K | $1.1M | $1.7M | $1.0M | ||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 523.0K | 1.1M | 233.0K | 284.0K | 205.0K |
Most recent annual filing with the SEC: March 3, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.